All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
Nuplazid (pimavanserin) is already FDA-approved to treat psychosis caused by Parkinson's disease, but Acadia's hope to expanding that use to the Alzheimer's population were shot down by a complete ...
The Senate Finance Committee voted along party lines to send Kennedy’s bid to lead the Department of Health and Human ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
Two more minimalistic designs considered were reminiscent of the Nutrition Facts boxes on the back panel and called the amount of specific nutrients in a serving. In the proposed rule, FDA decided ...
During its 2019 hearing, several members of the FDA panel stated a risk evaluation and mitigation strategy was needed to manage the increased DKA risk observed during inTANDEM3. As Healio ...
"Roche’s STI assay panels gain FDA 510(k) clearance and CLIA waiver" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results